Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$213,078
-$3,686 QoQ
Shares Held
425
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#2,253
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Clifford Group, LLC holds $459,940 across 2 Diagnostics & Research names. TMO ranks #2 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,296 | $246,862 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
425 | $213,078 |
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,078 | 425 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $216,764 | 441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $282,771 | 488 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $241,054 | 497 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $201,513 | 497 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $257,259 | 517 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $254,912 | 490 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $304,336 | 492 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $286,454 | 518 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $301,066 | 518 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $273,887 | 516 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $277,381 | 548 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $289,571 | 555 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $316,427 | 549 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $302,328 | 549 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||